SCICLONE PHARMACEUTICALS INC (SCLN) Stock News

Technical Snapshots for These Drug Makers Stocks -- SciClone Pharma, Synergy Pharma, Novo Nordisk, and United Therapeutics

Mentions: SGYP NVO UTHR

Consortium Led By GL Capital Completes Acquisition Of SciClone

NMI Holdings and Axcelis Technologies Set to Join S&P SmallCap 600

Mentions: ACLS NMIH FTV LDR ...

Breakfast Technical Briefing on Drug Makers Stocks -- Depomed, Synergy Pharma, Novo Nordisk, and SciClone Pharma

Mentions: DEPO SGYP NVO

SciClone Pharmaceuticals, Inc. (SCLN): Earnings News

SCLN – Beats Wall Street consensus EPS estimates by $0.03 and beats on revenues.

SciClone Pharmaceuticals, Inc. (SCLN): M&A News

SCLN – SciClone Pharma in proxy statement discloses non-binding competing bid for $12.00/share.

33 Stocks Moving In Thursday's Mid-Day Session

Gainers

Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares jumped 75.5 percent to $2.93 after jumping 14.38 percent on ...

Mentions: ACLS CLSN GLUU INFI ...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of SciClone Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 30, 2017

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of SciClone Pharmaceuticals, Inc. - SCLN

SciClone Announces End Of Go-Shop Period With No Parties Designated As Excluded Parties

SciClone Reports Second Quarter 2017 Financial Results

Lifshitz&Miller LLP Announces Investigation of ARI Network Services, Inc., DuPont Fabros Technology, Inc., Nexvet Biopharma Public Limited Company, PAREXEL International Corporation, Rice Energy Inc. and SciClone Pharmaceuticals, Inc.

Mentions: NVET PRXL ARIS DFT ...

Daily Technical Summary Reports on Drug Makers Stocks -- Apricus Biosciences, DURECT, Sucampo Pharma, and SciClone Pharma

Mentions: APRI DRRX SCMP

INVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of SciClone Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm for Additional Information

SCICLONE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of SciClone Pharmaceuticals, Inc.

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of SciClone Pharmaceuticals Inc. to a Consortium is Fair to Shareholders

SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of SciClone Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm for Additional Information

SCICLONE PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of SciClone Pharmaceuticals Inc. to a Consortium is Fair to Shareholders – SCLN

SciClone Enters Into Definitive Merger Agreement To Be Acquired By Consortium Led By GL Capital